Lamotrigine
Product Images NDC 60760-543

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 60760-543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

543 (Lamotrigine 543 30)

543 (Lamotrigine 543 30)
Lamotrigine 25 mg tablets packaging label shows a quantity of 30 tablets. It is labeled by St. Mary's Medical Park Pharmacy in Oro Valley, AZ, with manufacturing credited to Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel. The label includes NDC 60760-543-30 and states storage instructions at controlled room temperature 15-30°C (59-86°F). Several placeholder fields for lot number, expiration date, and prescription number are visible.*
FDA Label Image

Chemical Structure (Lamotrigine 01)

Chemical Structure (Lamotrigine 01)
Chemical structure of lamotrigine showing a triazine ring bonded to a chlorophenyl group with amino substituents.*
FDA Label Image

Figure 1 (Lamotrigine 02)

Figure 1 (Lamotrigine 02)
A survival analysis curve chart depicting cumulative failure probability (%) over weeks for Lamotrigine versus Placebo. The graph includes two curves, one labeled Lamotrigine and the other Placebo, with failure probability increasing over time, and censored data points marked on the curves.*
FDA Label Image

Figure 2 (Lamotrigine 03)

Figure 2 (Lamotrigine 03)
A Kaplan-Meier survival curve comparing failure probability (%) over time (weeks) between Lamotrigine and placebo groups. The x-axis represents weeks, and the y-axis shows failure probability in percentage. The graph includes censored data points indicated on the curves for both groups.*
FDA Label Image

Image (Lamotrigine 04)

Image (Lamotrigine 04)
Lamotrigine 25 mg white oval tablet with 'LMT 25' debossed on one side. This tablet is associated with ST. MARY'S MEDICAL PARK PHARMACY as the labeler. The image shows a single scored tablet likely used for oral administration.*
FDA Label Image

Image (Lamotrigine 05)

Image (Lamotrigine 05)
Lamotrigine 100 mg tablet is an oval, white scored pill imprinted with LMT above the score and 100 below the score. The tablet is associated with ST. MARY'S MEDICAL PARK PHARMACY and has a product NDC of 60760-543.*
FDA Label Image

Image (Lamotrigine 06)

Image (Lamotrigine 06)
Lamotrigine 150 mg white oval tablet engraved with LMT above 150 on one side. The product is labeled by ST. MARY'S MEDICAL PARK PHARMACY.*
FDA Label Image

Image (Lamotrigine 07)

Image (Lamotrigine 07)
Lamotrigine 200 mg tablet, white and round, scored on one side with the imprint 'LMT 200'. The image shows a single film-coated tablet without packaging. Labeler is ST. MARY'S MEDICAL PARK PHARMACY, product NDC 60760-543.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.